{"id":"W2766150197","doi":"10.1016/j.jval.2017.08.1170","title":"Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Novartis (Canada)","funders":"","keywords":"Sacubitril, Valsartan; Valsartan; Sacubitril; Medicine; Enalapril; Heart failure; Ejection fraction; Number needed to treat; Internal medicine; Population; Cardiology; Emergency medicine; Angiotensin-converting enzyme; Relative risk; Confidence interval; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000540779,0.0001781989,0.0004839644,0.0004868846,0.000930442,0.001195817,0.000658287,0.0003840919,0.004401786],"category_scores_gemma":[0.003703968,0.0001455387,0.0005041127,0.000906726,0.0004013475,0.0003357484,0.0003555335,0.001099516,0.0002020169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01846685,"about_ca_system_score_gemma":0.05012007,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.900807,"about_ca_topic_score_gemma":0.9708697,"domain_scores_codex":[0.9990138,0.0001736803,0.00007906255,0.0000870561,0.0003012714,0.0003450628],"domain_scores_gemma":[0.9975376,0.000209876,0.0004780705,0.00003636686,0.0007053704,0.001032648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00735911,0.003048728,0.5352987,0.0006962849,0.0007879121,0.0005395755,0.0003908543,0.003541337,0.002800189,0.002434955,0.05218787,0.3909145],"study_design_scores_gemma":[0.001190842,0.0008290563,0.9760748,0.0004455779,0.0005988232,0.0003038598,0.0007670853,0.004515992,0.0008193323,0.0008489641,0.01354805,0.00005761317],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.934984,0.01389625,0.0006781852,0.02082955,0.0003586149,0.0002245456,0.003679331,0.0001768829,0.0251727],"genre_scores_gemma":[0.9940367,0.001738018,0.0009396533,0.001522284,0.00008939049,0.00001766587,0.0005685212,0.00001895401,0.001068883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09919298,"threshold_uncertainty_score":0.1995543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04549424147602688,"score_gpt":0.334384230025348,"score_spread":0.2888899885493211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}